Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-17

Clinical Trial Update: Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, placebo-controlled study of outpatient intravenous ketamine for Complex Regional Pain Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Drexel University College of Medicine | Conditions: Complex Regional Pain Syndrome | Phase 2 | Status: COMPLETED